Montaña E, Rozadilla A, Nolla J M, Gomez N, Escofet D R, Soler J
Endocrine Unit, Ciutat Sanitaria i Universitaria de Bellvitge, Hospital de Bellvitge, Barcelona, Spain.
Ann Rheum Dis. 1995 Jul;54(7):582-6. doi: 10.1136/ard.54.7.582.
To determine whether limited joint mobility (LJM) is associated with microalbuminuria in type I diabetes mellitus.
Joint mobility was measured in a control group of 63 healthy subjects and in 63 type I diabetic patients, older than 18 years (mean 31.7 years, range 18-57), recruited from the outpatient clinic of the Endocrine Unit. Patients with established diabetic nephropathy (proteinuria or increased creatinine) were excluded. Joint mobility was assessed qualitatively with the prayer manoeuvre and quantitatively by measuring the angles of maximal flexion and extension of the fifth and third metacarpophalangeal (MCP) joints and wrist. Diabetic retinopathy was assessed by direct ophthalmoscopy. Urinary albumin excretion (UAE) was determined in at least two 24 hour urine samples.
Joint mobility was limited in diabetic patients compared with control subjects. Diabetic patients with LJM had longer duration of diabetes (12.1 (SD 6.4) years compared with 6.9 (5.7) years; p < 0.001). Joint mobility was limited in patients with retinopathy: prayer manoeuvre was positive in 96.4% of patients with retinopathy, but in only 40.0% of patients with no retinopathy (p < 0.001); mobility of MCP joints and wrist was limited in diabetic patients with retinopathy even when the longer duration of their diabetes was taken into consideration. Microalbuminuria, present in 11 patients (17.5%), was associated with LJM: prayer manoeuvre was positive in 90.9% of patients with microalbuminuria, but in only 57.4% of patients with normal UAE (p < 0.05). Maximal flexion of MCP joints was reduced in patients with microalbuminuria. Microalbuminuria, but not LJM, was associated with risk factors of cardiovascular disease.
LJM is associated with microalbuminuria and retinopathy in type I diabetes. The association is independent of age and duration of diabetes.
确定I型糖尿病患者的关节活动受限(LJM)是否与微量白蛋白尿有关。
对63名健康受试者组成的对照组以及从内分泌科门诊招募的63名年龄超过18岁(平均31.7岁,范围18 - 57岁)的I型糖尿病患者进行关节活动度测量。排除已确诊糖尿病肾病(蛋白尿或肌酐升高)的患者。通过祈祷动作定性评估关节活动度,并通过测量第五和第三掌指(MCP)关节以及腕关节的最大屈伸角度进行定量评估。通过直接检眼镜检查评估糖尿病视网膜病变。在至少两份24小时尿液样本中测定尿白蛋白排泄量(UAE)。
与对照组相比,糖尿病患者的关节活动受限。患有LJM的糖尿病患者糖尿病病程更长(分别为12.1(标准差6.4)年和6.9(5.7)年;p < 0.001)。视网膜病变患者的关节活动受限:96.4%的视网膜病变患者祈祷动作呈阳性,而无视网膜病变患者中仅40.0%呈阳性(p < 0.001);即使考虑到糖尿病病程较长,视网膜病变的糖尿病患者MCP关节和腕关节的活动度仍受限。11名患者(17.5%)存在微量白蛋白尿,其与LJM有关:90.9%的微量白蛋白尿患者祈祷动作呈阳性,而UAE正常的患者中仅57.4%呈阳性(p < 0.05)。微量白蛋白尿患者MCP关节的最大屈曲度降低。微量白蛋白尿而非LJM与心血管疾病危险因素有关。
I型糖尿病中LJM与微量白蛋白尿及视网膜病变有关。这种关联独立于年龄和糖尿病病程。